Eveready Industries has launched the 'Eveready ULTIMA' liquid vaporiser, entering the ₹2,800 crore portable mosquito repellent segment. This strategic move aims to diversify revenue away from traditional battery and flashlight sales. With Q1 FY27 profits up 22.3% and a target to become debt-free within four to five quarters, investors are tracking how the company balances its core operations with new consumer products.
Eveready Industries is expanding its product portfolio beyond its traditional battery and flashlight business by entering the home-care segment. The company has officially launched the 'Eveready ULTIMA' liquid vaporiser, a portable device designed to work without relying on fixed electrical plug-points. This product targets a segment of the Indian household insecticide market, which is valued at approximately ₹2,800 crore, out of a total category size of roughly ₹5,000 crore.
Strategic Pivot and Financial Health
This move represents a clear effort by Eveready to reduce its long-term reliance on its legacy battery and lighting business. While batteries and flashlights have historically provided the bulk of the company's revenue, management is now prioritizing a shift toward a more balanced portfolio that includes new consumer categories. As of October 7, 2026, the company’s stock was trading in the range of ₹318 to ₹320.
Financially, the company has shown signs of stability. In the first quarter of the 2027 financial year, Eveready reported a consolidated net profit of ₹37 crore, marking a 22.3% increase compared to the same period the previous year. Revenue for the quarter grew by 9% to ₹407.7 crore. Additionally, the company has set a target to become debt-free within the next four to five quarters, a goal that investors are monitoring as it pursues this new expansion.
Operational Growth and Future Outlook
Even as it diversifies, Eveready is not slowing down its core operations. In May 2026, the company commissioned a new alkaline battery manufacturing facility in Jammu. This plant has an annual capacity of 456 million batteries, allowing the company to meet demand while managing its operational costs.
However, the path forward involves significant challenges. The home-care and insecticide sector in India is highly competitive, dominated by well-established domestic and multinational players with deep distribution networks. To succeed, Eveready will need to effectively leverage its existing reach to gain market share in the insecticide segment.
Investors should also watch for potential pressure on profit margins. The company remains exposed to raw material price volatility, particularly the cost of zinc and other key inputs required for battery production. Future performance will depend on the company's ability to maintain its 14.89% EBITDA margins while investing in new product categories and managing the operational risks of scaling its home-care line.